Dr. Jeffrey H Lipton

Dr. Jeffrey H Lipton is a researcher for the University Health Network, one of the largest cancer research institutes in North America.  
- Professor of Medicine, University of Toronto, Ontario, Canada
- Chronic Myelogenous Leukemia Group, Department of Hematology/Medical Oncology, Princess Margaret Hospital, Toronto, Canada

'' I am involved in clinical research at the phase II and III levels on the therapy of chronic myeloid leukemia. This involves targeted therapy and combination therapy with biological modifiers. The interest in targeted therapy extends into the phase II study of signal transduction inhibitors in the therapy of myelodysplasia.

The second aspect of my clinical research involves outcome analysis in allogeneic stem cell transplant and the prevention and therapy of side effects, particularly fungal infections. I am involved in a number of phase II and III studies of new antifungals.''

Extract of http://www.uhnresearch.ca/researchers/profile.php?lookup=3564 

                  

____________________________________________________________________________________________________________
Living with chronic myeloid leukemia - Tasigna              (featuring Dr. Lipton)                       Video
Chronic myeloid leukemia, or CML, was once considered a death sentence but new treatment options have turned CML into a chronic, yet manageable disease for most patients.
August 2010, Info4YourLife
____________________________________________________________________________________
New leukemia treatment - Sprycel                    (featuring Dr. Lipton)                Video
2007, by Info4YourLife
____________________________________________________________________________________